Cerebrovasculature & ApoE

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of neurodegenerative and cardiovascular diseases. This feed focuses on the role of this protein in cerebrovasculature and cerebrovascular dysfunction.

October 15, 2020
Open Access

Neuroprotective pentapeptide, CN-105, improves outcomes in translational models of intracerebral hemorrhage

BioRxiv : the Preprint Server for Biology
H. WangDaniel T. Laskowitz
June 9, 2020
Open Access

Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease

Oxidative Medicine and Cellular Longevity
Abdullah Al MamunMohamed M Abdel-Daim
May 18, 2020

Incidence and risk factors of vascular dementia in Thai stroke patients

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
Pornpatr A DharmasarojaThammanard Charernboon
July 28, 2020
Open Access

A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy

Journal of Neuroinflammation
Xavier TaylorCristian A Lasagna-Reeves
August 28, 2020

High-Density Lipoprotein Carries Markers That Track With Recovery From Stroke

Circulation Research
Deanna L PlubellNathalie Pamir
September 29, 2020

Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging

Journal of Alzheimer's Disease : JAD
Ying XiaAIBL Research Group
June 12, 2020
Open Access

Spatial distribution and cognitive impact of cerebrovascular risk-related white matter hyperintensities

BioRxiv : the Preprint Server for Biology
Michele VeldsmanThomas E Nichols
August 28, 2020
Comment / Editorial

Extending AD biomarker studies into the Hispanic community

David A Bennett, David S Knopman
January 1, 2021
Open Access

Cognitive impact of COVID-19: looking beyond the short term

Alzheimer's Research & Therapy
Scott MinersSeth Love
December 16, 2020

Vascular ApoE4 Impairs Behavior by Modulating Gliovascular Function

Yu YamazakiGuojun Bu
September 5, 2020
Open Access

Predictors of olfactory decline in aging: A longitudinal population-based study

The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
Ingrid EkströmErika J Laukka
November 6, 2020
Open Access

APOE2: protective mechanism and therapeutic implications for Alzheimer's disease

Molecular Neurodegeneration
Zonghua LiGuojun Bu
January 12, 2021
Open Access

Variants in PPP2R2B and IGF2BP3 are associated with higher tau deposition

Brain Communications
Vijay K RamananPrashanthi Vemuri
December 14, 2020
Open Access

Deregulation of brain endothelial CD2AP in Alzheimer's disease impairs Reelin-mediated neurovascular coupling

BioRxiv : the Preprint Server for Biology
M. VandalMinh Dang Nguyen
June 25, 2020
Open Access

ABCA1/ApoE/HDL Signaling Pathway Facilitates Myelination and Oligodendrogenesis after Stroke

International Journal of Molecular Sciences
Li LiXu Cui

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

© 2021 Meta ULC. All rights reserved